WASHINGTON — The Meals and Drug Administration has so much on its plate in 2024 with the reorganizations of its meals heart and the workplace that inspects FDA-regulated amenities.
Amid that large reorganization, the FDA additionally will lose certainly one of its most influential leaders. Janet Woodcock is retiring in the beginning of the 12 months after many years of service. She helped information among the most impactful adjustments to the regulation of medication and was a gradual hand on the company’s tiller all through a number of administrations.
The company additionally will doubtless have to resolve whether or not to take motion on the regulation of lab-developed diagnostics, and it’s getting critical about making medical trials extra consultant of the folks that medicine deal with.
Get limitless entry to award-winning journalism and unique occasions.